HAB Pharma opens new manufacturing facility in Dehradun

HAB Pharmaceutical & Research Ltd. has acquired a 10-acre site in Dehradun to enhance its manufacturing capabilities. The new facility will produce Metered Dose Inhalers and explore biologics for autoimmune disorders, expanding its healthcare offerings. This acquisition marks a significant step in HAB Pharma's growth strategy, as it aims to meet increasing demand in the healthcare sector. The company already operates two facilities in India and is known for its innovative products and high-quality manufacturing. HAB Pharma's expansion reflects its commitment to advancing healthcare solutions and solidifying its role as a key contract manufacturer for major pharmaceutical companies.